Multimodal Intervention

A randomized, open-label trial of a Multimodal Intervention versus standard care in cancer patients with Cachexia

This multinational, phase III clinical trial seeks to investigate the hypothesis that a multimodal intervention delivered during chemotherapy in the advanced lung or pancreatic cancer is effective in preventing and/or delaying cancer cachexia, and as a consequence, will improve weight, food intake, physical function and quality of life.

If proven positive, the proposed cachexia intervention can be immediately adopted into current practice and can be easily implemented across the healthcare system to become the new standard of care.